These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 24037346)
1. Clinical significance of serum soluble interleukin-2 receptor-α in extranodal natural killer/T-cell lymphoma (ENKTL): a predictive biomarker for treatment efficacy and valuable prognostic factor. Wang L; Liao DZ; Zhang J; Xia ZJ; Peng XW; Lu Y Med Oncol; 2013 Dec; 30(4):723. PubMed ID: 24037346 [TBL] [Abstract][Full Text] [Related]
2. CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type. Li P; Jiang L; Zhang X; Liu J; Wang H BMC Cancer; 2014 Nov; 14():890. PubMed ID: 25429803 [TBL] [Abstract][Full Text] [Related]
3. CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis. Wang L; Wang Z; Xia ZJ; Lu Y; Huang HQ; Zhang YJ Tumour Biol; 2015 Sep; 36(10):7717-23. PubMed ID: 25935537 [TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphoma. Yoo C; Yoon DH; Jo JC; Yoon S; Kim S; Lee BJ; Huh J; Lee SW; Suh C Ann Hematol; 2014 Jun; 93(6):995-1000. PubMed ID: 24441948 [TBL] [Abstract][Full Text] [Related]
5. Circulating Low Absolute CD4+ T Cell Counts May Predict Poor Prognosis in Extranodal NK/T-Cell Lymphoma Patients Treating with Pegaspargase-Based Chemotherapy. Zhang YP; Zhang R; Zhu HY; Wang L; Wu YJ; Liang JH; Shi WY; Liu H; Xu W; Li JY Cancer Res Treat; 2019 Jan; 51(1):368-377. PubMed ID: 29764116 [TBL] [Abstract][Full Text] [Related]
6. High IL-6 expression in the tumor microenvironment is associated with poor prognosis of patients with extranodal natural / killer T-cell lymphoma (ENKTL). Rong Q; Gao Y; Cai Q; Wang X; Bai B; Ping L; He H; Rao H; Zhang Y; Li Z; Cai Q; Jiang W; Huang H Expert Rev Anticancer Ther; 2021 Jan; 21(1):121-127. PubMed ID: 33397158 [No Abstract] [Full Text] [Related]
7. Prognostic role of ABO blood type in patients with extranodal natural killer/T cell lymphoma, nasal type: a triple-center study. Li YJ; Yi PY; Li JW; Liu XL; Tang T; Zhang PY; Jiang WQ Chin J Cancer; 2017 Jul; 36(1):62. PubMed ID: 28756771 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma. Gupta M; Stenson M; O'Byrne M; Maurer MJ; Habermann T; Cerhan JR; Weiner GW; Witzig TE Ann Oncol; 2016 Jan; 27(1):165-72. PubMed ID: 26487586 [TBL] [Abstract][Full Text] [Related]
9. Serum C-reactive protein (CRP) as a simple and independent prognostic factor in extranodal natural killer/T-cell lymphoma, nasal type. Li YJ; Li ZM; Xia Y; Huang JJ; Huang HQ; Xia ZJ; Lin TY; Li S; Cai XY; Wu-Xiao ZJ; Jiang WQ PLoS One; 2013; 8(5):e64158. PubMed ID: 23724031 [TBL] [Abstract][Full Text] [Related]
10. A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type. Xu PP; Xiong J; Cheng S; Zhao X; Wang CF; Cai G; Zhong HJ; Huang HY; Chen JY; Zhao WL EBioMedicine; 2017 Nov; 25():41-49. PubMed ID: 29056540 [TBL] [Abstract][Full Text] [Related]
11. Prognostic importance of the soluble form of IL-2 receptorα (sIL-2Rα) and its relationship with surface expression of IL-2Rα (CD25) of lymphoma cells in diffuse large B-cell lymphoma treated with CHOP-like regimen with or without rituximab: a retrospective analysis of 338 cases. Hashimoto Y; Yokohama A; Saitoh A; Nakahashi H; Toyama K; Mitsui T; Koiso H; Saitoh T; Handa H; Uchiumi H; Jinbo T; Murayama K; Matsumoto M; Sawamura M; Karasawa M; Murakami H; Hirato J; Nojima Y; Kojima M; Tsukamoto N J Clin Exp Hematop; 2013; 53(3):197-205. PubMed ID: 24369221 [TBL] [Abstract][Full Text] [Related]
12. Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients. Wang L; Xia ZJ; Huang HQ; Lu Y; Zhang YJ Int J Hematol; 2012 Nov; 96(5):617-23. PubMed ID: 22983648 [TBL] [Abstract][Full Text] [Related]
13. Increased serum levels of interleukin-15 correlate with negative prognostic factors in extranodal NK/T cell lymphoma. Wang H; Zhu JY; Liu CC; Zhu MY; Wang JH; Geng QR; Lu Y Med Oncol; 2015 Jan; 32(1):370. PubMed ID: 25428383 [TBL] [Abstract][Full Text] [Related]
14. Low level of high-density lipoprotein cholesterol correlates with poor prognosis in extranodal natural killer/T cell lymphoma. Wang L; Chi PD; Chen H; Xiang J; Xia ZJ; Zhang YJ Tumour Biol; 2014 Mar; 35(3):2141-9. PubMed ID: 24122233 [TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of elevated levels of serum soluble interleukin-2 receptor alpha (sIL-2Rα) in patients with non-Hodgkin's lymphoma. Jo SA; Hwang SH; Chang CL; Kim SY; Shin HJ; Chung JS; Sol MY; Lee EY Korean J Lab Med; 2010 Dec; 30(6):600-5. PubMed ID: 21157146 [TBL] [Abstract][Full Text] [Related]
16. Fasting blood glucose is a novel prognostic indicator for extranodal natural killer/T-cell lymphoma, nasal type. Cai Q; Luo X; Liang Y; Rao H; Fang X; Jiang W; Lin T; Lin T; Huang H Br J Cancer; 2013 Feb; 108(2):380-6. PubMed ID: 23299534 [TBL] [Abstract][Full Text] [Related]
17. Serum aspartate aminotransferase, a novel potential biomarker of prognosis in extranodal natural killer/T cell lymphoma, nasal type. Yao N; Hou Q; Liang Y; Cao X; Sun B; Wei L; Sun R; Cao J Cancer Biomark; 2024; 39(4):265-275. PubMed ID: 38108343 [TBL] [Abstract][Full Text] [Related]
18. Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease. Lim SH; Hong JY; Lim ST; Hong H; Arnoud J; Zhao W; Yoon DH; Tang T; Cho J; Park S; Ko YH; Kim SJ; Suh C; Lin T; Kim WS Ann Oncol; 2017 Sep; 28(9):2199-2205. PubMed ID: 28911074 [TBL] [Abstract][Full Text] [Related]
19. CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK/T cell lymphoma, nasal type. Wang L; Wang H; Li PF; Lu Y; Xia ZJ; Huang HQ; Zhang YJ Ann Hematol; 2015 Aug; 94(8):1381-8. PubMed ID: 25865943 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of 25-hydroxy vitamin D in extranodal NK/T cell lymphoma. Mao J; Yin H; Wang L; Wu JZ; Xia Y; Zhu HY; Fan L; Li JY; Liang JH; Xu W Ann Hematol; 2021 Feb; 100(2):445-453. PubMed ID: 33140135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]